Gofen & Glossberg’s St Jude Medical STJ Stock Holding History

Gofen & Glossberg’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,177	Closed	-$255K	–	486
2016 Q4	$255K	Sell	3,177 -650	-17%	-$51.6K	0.01%	371
2016 Q3	$305K	Hold	3,827	–	–	0.01%	347
2016 Q2	$299K	Sell	3,827 -800	-17%	-$57K	0.01%	353
2016 Q1	$254K	Sell	4,627 -87	-2%	-$4.74K	0.01%	382
2015 Q4	$291K	Hold	4,714	–	–	0.01%	349
2015 Q3	$297K	Hold	4,714	–	–	0.01%	339
2015 Q2	$344K	Hold	4,714	–	–	0.01%	330
2015 Q1	$308K	Sell	4,714 -528	-10%	-$35.1K	0.01%	348
2014 Q4	$341K	Hold	5,242	–	–	0.01%	325
2014 Q3	$315K	Hold	5,242	–	–	0.01%	335
2014 Q2	$363K	Hold	5,242	–	–	0.02%	314
2014 Q1	$353K	Sell	5,242 -127	-2%	-$8.27K	0.02%	313
2013 Q4	$333K	Hold	5,369	–	–	0.02%	317
2013 Q3	$288K	Hold	5,369	–	–	0.01%	332
2013 Q2	$245K	Buy	+5,369	New	+$233K	0.01%	341

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gofen & Glossberg's STJ Position: Q1 2017 in Review

Gofen & Glossberg sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,177 shares — an estimated $255K sold.

Gofen & Glossberg first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $363K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Gofen & Glossberg reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Gofen & Glossberg sold 3,177 St Jude Medical shares in Q1 2017, an estimated $255K.
Gofen & Glossberg first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Gofen & Glossberg's St Jude Medical position peaked at $363K in Q2 2014.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gofen & Glossberg's 13F filing for Q1 2017, filed 11 May 2017.